3
Fig. S1 0.00 0.50 1.00 1.50 2.00 2.50 3.00 HUVE Cs HDF Ns HUVE Cs HDF Ns Transwell CM Relative total length ** * contr ol 200ng/ ml 400ng/ ml TIMP-1 100ng/ ml 0.00 0.50 1.00 1.50 2.00 * ** GFP WT Mutant TIMP-1 TIMP-1 0.00 0.50 1.00 1.50 2.00 ** Relative total length Relative total length Supplementary data, Liu et al., 200 Contr ol TIMP -1 MMP-2/9 inhibitor MMP-1 inhibitor ** ** 0.00 0.50 1.00 1.50 2.00 Relative total length Contr ol TIMP -1 TIMP-1 + MMP-9 MMP -9 0.00 0.50 1.00 1.50 2.00 ** Relative total length A B D E F Fig. S1. Quantitative analysis of vessel formation by relative total length. (A) Fibroblast-conditioned media promotes vessel formation. (B) Exogenous TIMP-1 enhances vessel formation. (C) Removal of TIMP-1 by siRNA from fibroblasts reduces conditioned- media induced vessel formation. (D) TIMP-1 promotes vessel formation in a MMP-dependent manner. (E) Inhibition of MMP-2/9 enhances vessel formation. (F) TIMP-1-enhanced vessel formation is abolished by active MMP-9. *P < 0.05, **P < 0.01 compared to respective control. C contr ol TIMP-1 siRNA TIMP-1 siRNA + TIMP-1 Fibroblast- conditioned media Con siRNA 0.00 0.50 1.00 1.50 2.00 2.50 Relative total length **

Fig. S1 HUVECs HDFNs HUVECs HDFNs Transwell CM Relative total length ** * control 200ng/ml400ng/ml TIMP-1 100ng/ml * ** GFP WT Mutant TIMP-1 TIMP-1 **

Embed Size (px)

Citation preview

Page 1: Fig. S1 HUVECs HDFNs HUVECs HDFNs Transwell CM Relative total length ** * control 200ng/ml400ng/ml TIMP-1 100ng/ml * ** GFP WT Mutant TIMP-1 TIMP-1 **

Fig. S1

0.00

0.50

1.00

1.50

2.00

2.50

3.00

HU

VE

Cs H

DF

Ns

HU

VE

Cs H

DF

Ns

TranswellCM

Rel

ativ

e t

ota

l le

ngt

h

**

*

cont

ro

l

20

0ng

/m

l

40

0ng

/m

l

TIMP-1

10

0ng

/m

l

0.00

0.50

1.00

1.50

2.00

* **

GFP WT Mutant TIMP-1 TIMP-1

0.00

0.50

1.00

1.50

2.00 **

Rel

ativ

e t

ota

l le

ngt

hR

ela

tive

tot

al

len

gth

Supplementary data, Liu et al., 2007

Con

tro

l

TIM

P-1

MM

P-2

/9

inh

ibito

r

MM

P-1

in

hib

itor

** **

0.00

0.50

1.00

1.50

2.00

Rel

ativ

e t

ota

l le

ngt

h

Con

tro

l

TIM

P-1

TIM

P-1

+

MM

P-9 M

MP

-9

0.00

0.50

1.00

1.50

2.00

**

Rel

ativ

e t

ota

l le

ngt

h

A B

D

E F

Fig. S1. Quantitative analysis of vessel formation by relative total length. (A) Fibroblast-conditioned media promotes vessel formation. (B) Exogenous TIMP-1 enhances vessel formation. (C) Removal of TIMP-1 by siRNA from fibroblasts reduces conditioned-media induced vessel formation. (D) TIMP-1 promotes vessel formation in a MMP-dependent manner. (E) Inhibition of MMP-2/9 enhances vessel formation. (F) TIMP-1-enhanced vessel formation is abolished by active MMP-9. *P < 0.05, **P < 0.01 compared to respective control.

C

cont

ro

l

TIM

P-1

si

RN

A

TIM

P-1

si

RN

A

+

TIM

P-1

Fibroblast-conditioned media

Con

si

RN

A

0.00

0.50

1.00

1.50

2.00

2.50

Rel

ativ

e t

ota

l le

ngt

h

**

Page 2: Fig. S1 HUVECs HDFNs HUVECs HDFNs Transwell CM Relative total length ** * control 200ng/ml400ng/ml TIMP-1 100ng/ml * ** GFP WT Mutant TIMP-1 TIMP-1 **

0.000

0.025

0.050

0.075

0.100conTIMP-1

Abs

orb

anc

e

A

0h 24h 48h

Con

TIMP-1

B

ED

C

0h 24h

Fig. S2

Supplementary data, Liu et al., 2007

Fig. S2. TIMP-1 does not affect proliferation and migration of HUVECs. (A) HUVECs were cultured in a 96-well plate and incubated without (con) or with TIMP-1 (400ng/ml). At indicated time points cell number was determined using methylene blue assay. (B-E) HUVECs were plated in 24-well plate and migration was determined by wound healing assay. The monolayers were wounded and incubated without (con) (B and C) or with TIMP-1 (400ng/ml) (D and E).

Page 3: Fig. S1 HUVECs HDFNs HUVECs HDFNs Transwell CM Relative total length ** * control 200ng/ml400ng/ml TIMP-1 100ng/ml * ** GFP WT Mutant TIMP-1 TIMP-1 **

Rel

ativ

e

are

a

0.00

1.00

2.00

con 0.01 0.03 0.1 0.3 1 3 10

MMP-2/9 inhibitor (M)

** **

Fig. S3

Supplementary data, Liu et al., 2007

Fig. S3. Inhibition of MMP-2/9 enhances vessel formation. HUVECs were grown inthree dimensional collagen gel for five days without (con) or with indicated concentrations of MMP-2/9 inhibitor. **P < 0.01 compared to control.